comparemela.com
Home
Live Updates
Novartis's Scemblix Gets FDA Approval for Two Indications in
Novartis's Scemblix Gets FDA Approval for Two Indications in
Novartis's Scemblix Gets FDA Approval for Two Indications in Chronic Myeloid Leukemia
By Cristina Roca
Novartis AG said late Friday that the U.S. Food & Drug Administration has approved Scemblix for two indications in chronic myeloid leukemia.
The Swiss... | November 1, 2021
Related Keywords
Switzerland ,
Swiss ,
Cristina Roca ,
Us Food Drug Administration ,
,
Drug Administration ,
Dow Jones ,
Novartis Ag Stock Exchange ,
News ,
Information ,
Press Release ,
Y ,
Ristina ,
Moca ,
Novartis ,
G ,
Aid ,
Gate ,
Friday ,
Hat ,
The ,
Wood ,
Drug ,
Administration ,
Gas ,
Approved ,
Scemblix ,
Or ,
Two ,
Indications ,
N ,
Hronic ,
Amyeloid ,
He Novn Ch0012005267 ,